Stable overexpression of MEN1 suppresses tumorigenicity of RAS. (Q40918854)

24 September 2017

Stable overexpression of MEN1 suppresses tumorigenicity of RAS. (English)

1 reference

24 September 2017

1 reference

7

Collins FS

1 reference

24 September 2017

Kim YS

1

1 reference

24 September 2017

Burns AL

2

1 reference

24 September 2017

Goldsmith PK

3

1 reference

24 September 2017

Heppner C

4

1 reference

24 September 2017

Park SY

5

1 reference

24 September 2017

Chandrasekharappa SC

6

1 reference

24 September 2017

Spiegel AM

8

1 reference

24 September 2017

Marx SJ

9

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

24 September 2017

1 reference

24 September 2017

18

1 reference

24 September 2017

5936-5942

1 reference

24 September 2017

43

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203005

24 September 2017

0 references

cites work

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Positional cloning of the gene for multiple endocrine neoplasia-type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Somatic mutation of the MEN1 gene in parathyroid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Wild-type p53 can inhibit oncogene-mediated focus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Menin, the product of the MEN1 gene, is a nuclear protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

PML, a growth suppressor disrupted in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Three different human tumor cell lines contain different oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

7 January 2021

Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

7 January 2021

Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

7 January 2021

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203005

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203005

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference